Covenant Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$3.99M |
| 2 |
TSMC
TSM
|
+$3.6M |
| 3 |
Boston Scientific
BSX
|
+$3.36M |
| 4 |
Strategy Inc
MSTR
|
+$1.67M |
| 5 |
Arm
ARM
|
+$924K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$4.57M |
| 2 |
Diamondback Energy
FANG
|
+$3.24M |
| 3 |
NVIDIA
NVDA
|
+$2.13M |
| 4 |
Apple
AAPL
|
+$2.07M |
| 5 |
Advanced Micro Devices
AMD
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.94% |
| 2 | Communication Services | 8.22% |
| 3 | Healthcare | 7.37% |
| 4 | Consumer Discretionary | 5.03% |
| 5 | Industrials | 4.92% |
Similar funds
Covenant Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Covenant Asset Management held 183 positions worth $652M, up 2.5% from $636M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Covenant Asset Management withdrew a net $43.8M in Q4 2024, closing 13 positions and reducing 88 holdings. Its most notable exit was Diamondback Energy, an estimated $3.24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Covenant Asset Management opened a new position in Stryker worth $3.87M.
- Covenant Asset Management's largest Q4 2024 buy was Stryker: 10,757 shares worth $3.87M.
- Covenant Asset Management added most to Arm in Q4 2024, an estimated $924K increase.
- Covenant Asset Management's biggest Q4 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $4.57M.
- Covenant Asset Management fully exited Diamondback Energy in Q4 2024, selling an estimated $3.24M.
- Covenant Asset Management's ten largest holdings make up 45% of its $652M portfolio in Q4 2024.
- Covenant Asset Management opened 8 new positions and closed 13 in Q4 2024.
- Covenant Asset Management's portfolio value rose 2.5% quarter-over-quarter to $652M.
Based on Covenant Asset Management's 13F filing for Q4 2024, filed 30 Jan 2025.